Roche Holding AG

OTC: RHHVF · Real-Time Price · USD
317.00
10.26 (3.34%)
At close: Aug 15, 2025, 3:54 PM
306.82
-3.21%
Pre-market: Aug 14, 2025, 09:30 AM EDT

Roche Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
62.4B 60.44B 63.28B 62.8B
Cost of Revenue
16.28B 16.36B 20.4B 19.65B
Gross Profit
46.11B 44.08B 42.88B 43.15B
Operating Income
13.42B 15.39B 17.48B 18.16B
Interest Income
260M 195M 67M 342M
Pretax Income
11.79B 14.08B 16.33B 17.4B
Net Income
8.28B 11.5B 12.42B 13.93B
Selling & General & Admin
14.9B 14.88B 12.53B 13.25B
Research & Development
15.3B 14.2B 16.02B 14.8B
Other Expenses
2.5B -392M -3.15B -3.05B
Operating Expenses
32.7B 28.69B 25.41B 25B
Interest Expense
1.4B 997M 690M 419M
Selling & Marketing Expenses
n/a n/a 9.64B 9.92B
Cost & Expenses
48.98B 45.05B 45.8B 44.65B
Income Tax Expense
2.61B 1.72B 2.8B 2.46B
Shares Outstanding (Basic)
802.31M 803.49M 800M 850M
Shares Outstanding (Diluted)
802M 804M 800M 860M
EPS (Basic)
10.32 14.31 15.53 16.39
EPS (Diluted)
10.32 14.30 15.53 16.20
EBITDA
16.62B 18.54B 21.53B 22.86B
EBIT
13.2B 15.08B 17.02B 17.82B
Depreciation & Amortization
3.42B 3.46B 3.82B 4.45B